These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37881790)

  • 21. Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain.
    Jones BD; Tochowicz A; Tang Y; Cameron MD; McCall LI; Hirata K; Siqueira-Neto JL; Reed SL; McKerrow JH; Roush WR
    ACS Med Chem Lett; 2016 Jan; 7(1):77-82. PubMed ID: 26819670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsin L silencing enhances arsenic trioxide mediated in vitro cytotoxicity and apoptosis in glioblastoma U87MG spheroids.
    Primon M; Huszthy PC; Motaln H; Talasila KM; Torkar A; Bjerkvig R; Lah Turnšek T
    Exp Cell Res; 2013 Oct; 319(17):2637-48. PubMed ID: 23968587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.
    Ettari R; Micale N; Grazioso G; Bova F; Schirmeister T; Grasso S; Zappalà M
    ChemMedChem; 2012 Sep; 7(9):1594-600. PubMed ID: 22753258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors.
    Shenoy RT; Sivaraman J
    J Struct Biol; 2011 Jan; 173(1):14-9. PubMed ID: 20850545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantum Mechanics/Molecular Mechanics Studies of the Mechanism of Cysteine Proteases Inhibition by Dipeptidyl Nitroalkenes.
    Arafet K; González FV; Moliner V
    Chemistry; 2020 Feb; 26(9):2002-2012. PubMed ID: 31692123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internalization of exogenous cystatin F supresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms.
    Colbert JD; Matthews SP; Kos J; Watts C
    J Biol Chem; 2011 Dec; 286(49):42082-42090. PubMed ID: 21956111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study.
    Lv BJ; Lindholt JS; Wang J; Cheng X; Shi GP
    Atherosclerosis; 2013 Sep; 230(1):100-105. PubMed ID: 23958260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
    Lynas JF; Hawthorne SJ; Walker B
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer.
    Fuchs N; Meta M; Lantzberg B; Bros M; Ling Kuan S; Weil T; Schirmeister T
    ChemMedChem; 2023 Aug; 18(15):e202300160. PubMed ID: 37222230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Cysteine Protease Inhibitor Derived from the
    Linhares DDC; Faria F; Kodama RT; Amorim AMXP; Portaro FCV; Trevisan-Silva D; Ferraz KF; Chudzinski-Tavassi AM
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.
    Banerjee S
    Biophys Chem; 2021 Feb; 269():106510. PubMed ID: 33285430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultraviolet A Enhances Cathepsin L Expression and Activity via JNK Pathway in Human Dermal Fibroblasts.
    Xu QF; Zheng Y; Chen J; Xu XY; Gong ZJ; Huang YF; Lu C; Maibach HI; Lai W
    Chin Med J (Engl); 2016 Dec; 129(23):2853-2860. PubMed ID: 27901001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptidyl alpha-fluorovinyl Michael acceptors: synthesis and activity against cysteine proteases.
    Steert K; El-Sayed I; Van der Veken P; Krishtal A; Van Alsenoy C; Westrop GD; Mottram JC; Coombs GH; Augustyns K; Haemers A
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6563-6. PubMed ID: 17936625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.
    Schwartz PA; Kuzmic P; Solowiej J; Bergqvist S; Bolanos B; Almaden C; Nagata A; Ryan K; Feng J; Dalvie D; Kath JC; Xu M; Wani R; Murray BW
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):173-8. PubMed ID: 24347635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warhead Reactivity Limits the Speed of Inhibition of the Cysteine Protease Rhodesain.
    Johe P; Jung S; Endres E; Kersten C; Zimmer C; Ye W; Sönnichsen C; Hellmich UA; Sotriffer C; Schirmeister T; Neuweiler H
    ACS Chem Biol; 2021 Apr; 16(4):661-670. PubMed ID: 33719398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantum mechanics-based scoring rationalizes the irreversible inactivation of parasitic Schistosoma mansoni cysteine peptidase by vinyl sulfone inhibitors.
    Fanfrlík J; Brahmkshatriya PS; Řezáč J; Jílková A; Horn M; Mareš M; Hobza P; Lepšík M
    J Phys Chem B; 2013 Dec; 117(48):14973-82. PubMed ID: 24195769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.
    Konjar S; Sutton VR; Hoves S; Repnik U; Yagita H; Reinheckel T; Peters C; Turk V; Turk B; Trapani JA; Kopitar-Jerala N
    Immunology; 2010 Oct; 131(2):257-67. PubMed ID: 20497254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of selective covalent cathepsin K inhibitors containing novel 4-cyanopyrimidine warhead based on quantum chemical calculations and binding mode analysis.
    Jia Y; Wang K; Wang H; Zhang B; Yang K; Zhang Z; Dong H; Wang J
    Bioorg Med Chem; 2022 Nov; 74():117053. PubMed ID: 36270112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-headed cathepsin B inhibitor devoid of warhead.
    Schenker P; Alfarano P; Kolb P; Caflisch A; Baici A
    Protein Sci; 2008 Dec; 17(12):2145-55. PubMed ID: 18796695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.